| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.38 | 0.01 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |